Detailed Mechanism Funding and Narrative

Years of mechanism: 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 1
Country/Region: Zimbabwe
Year: 2010
Main Partner: Not Available
Main Partner Program: NA
Organizational Type: Unknown
Funding Agency: Redacted
Total Funding: $12,503,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC): $2,883,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: Adult Care and Support (HBHC): $605,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Laboratory Infrastructure (HLAB): $610,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Biomedical Prevention: Blood Safety (HMBL): $690,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Treatment: Adult Treatment (HTXS): $100,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Sexual Prevention: Abstinence/Be Faithful (HVAB): $1,134,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Testing: HIV Testing and Counseling (HVCT): $1,780,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Sexual Prevention: Other Sexual Prevention (HVOP): $1,386,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Strategic Information (HVSI): $975,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: TB/HIV (HVTB): $1,495,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Health Systems Strengthening (OHSS): $645,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: Pediatric Care and Support (PDCS): $200,000

Mechanism and partner data have not been released by PEPFAR at this time.